Studies on pharmacokinetics of ferulic acid, Rhizoma Chuanxiong and Naodesheng capsule in rat / 中国中药杂志

<p><b>OBJECTIVE</b>To establish a RP-HPLC method to determine the pharmacokinetics of ferulaic acid of ferulaic acid, Rhizoma Chuanxiong extraction and Naodesheng capsule in rat and assess the effect of other components in medical material and in compound on the pharmacokinetics of ferulaic acid.</p><p><b>METHOD</b>The rats were orally treated with referential ferulaic acid, Rhizoma Chuanxiong extraction and Naodesheng capsule repectively. Blood samples were collected by cutting rats tails. Plasma was separated by centrifugation at 10,000 r x min(-1) for 10 min, and two-times methanol in volume was added to deposit proteins. After centrifugation, the upper liquid was transferred to filter. The concentration of ferulaic acid in serum was determined by RP-HPLC. The stationary phase was C18, and methanol-0.5% acetic acid (30:70) was taken as the mobile phase, A UV detector was used at 320 nm. The pharmacokinetic parameters were calculated with 3p97 program.</p><p><b>RESULT</b>A good linear relationship of ferulaic acid was obtained from 0.05-1 mg x L(-1), the lowest limits of determination were 13 microg x L(-1). The plasma concentration-time curves of ferulaic acid were fitted with two-compartment models properly. The pharmacokinetics parameterst AUC(0-t), Cmax, CL of ferulaic acid showed significant differences between referential group and the other groups.</p><p><b>CONCLUSION</b>The method applied for determination of ferulaic acid content in blood was simple, accurate and feasible for the study of ferulaic acid pharmacokinetics in rats. The results indicated that the other ingredients of Rhizoma Chuanxiong had remarkable influence on the pharmacokinetics of ferulaic acid. However, compatibility promotes the ferulic's absorption, enhances the ferulic's biological exploitability.</p>

Study on recombinant chicken ? interferon production in yeast Pichia pastoris and detection for its antiviral activity / 中国免疫学杂志

Objective:To obtain eukaryotic expressing protein of chicken interferon ? (ChIFN-?) and research its anti-virus activity.Methods: Chicken interferon ? mature protein gene was cloned and amplified by reverse transcripition-polymerase chain reaction(RT-PCR) from the total mRNA in the lymphocyte of chicken blood stimulated with ConA for 4～10 hours.The gene was inserted into the expression vector pPICZa-A,which had been cleaved by EcoR I and Xba I.The recombinant vector was linearized by Sac I and transferred into yeast Pichia pastoris,strain X33,anti-virus activity of the recombinant cytokine was detected by the classical experiment cell pathological effect inhibition assay.Results:The result showed that the preparation of recombinant interferon had higher anti-virus activity(10?48 U/ml).Conclusion: The recombinant chicken interferon ? with anti-virus bioactivity has been obtained.